castle trial safety
Chronic Disease Management vs Car‑T Trial Risks?
CD19 CAR-T therapy can deliver remission in refractory autoimmune disease, but the CASTLE trial reveals a notable side-effect profile that must be weighed against its benefits. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making health